Restart Life Sciences Corp.

C$0.08As of Sun 8 Nov 2026, 12:00 UTC
CSE:HEALHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (38.93%)
Div yield —
ROE (246.66%)
Biotechnology
Beta (5Y) (0.93)
PE TTM —
TSR TTM (15.79%)
Mkt cap C$5.001M
ROIC (126.14%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.076
(4.96%)
(68.66%)
Hold 8|9|11|5|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
20.66%
22.87%
19.95%
10.48%
Revenue$M
0.268
0.277
0.285
0.299
9.32%
10.21%
13.03%
12.26%
Peers (US$3.539M)
Cap (US$)
PE
2.993M
0.870x
Capital
TTM
5Y
10Y
Leveragex
0.116
(0.032)
(0.031)
EBIT/Intx
5.068
0.729
0.574
Own earn%
(19.09)
(121.57)
(122.47)
Sh yield%
28.21
36.22
34.40
Owners
Insiders/Inst%
4.45
24.88
Short interest%
3.30
SBC / revenue%
1.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
11–14
$1 testx
—
Incr. ROIC%
9